| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
ElectrocardiographyHeart (Hypertrophy)Histone deacetylaseCalcineurinFGF2Calmodulin dependent protein kinaseLeptinCell volumeIon channel (Anion)Ion channel (VRAC volume regulated anion channel)| 1 | 2009 | AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. | 
| + | - | nl | Circulation 119(10):e251-61 (2009) |
| 2 | 2010 | The role of microRNA-133 in cardiac hypertrophy uncovered. | 
| + | - | nl | Circ Res 106(1):16-8 (2010) Abdellatif M |
| 3 | 2011 | Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy. | 
| + | - | nl | J Biomed Biotechnol 2011(-):928326 (2011) |
| 4 | 2004 | Network integration of the adrenergic system in cardiac hypertrophy. | 
| + | - | nl | Cardiovasc Res 63(3):391-402 (2004) |
| 5 | 2004 | Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy. | 
| + | - | nl | Cardiovasc Res 63(3):403-13 (2004) |
| 6 | 2004 | Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes. | 
| + | - | nl | Cardiovasc Res 63(3):450-7 (2004) |
| 7 | 2004 | Fibroblast growth factor 2 isoforms and cardiac hypertrophy. | 
| + | - | nl | Cardiovasc Res 63(3):458-66 (2004) |
| 8 | 2004 | Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. | 
| + | - | nl | Cardiovasc Res 63(3):467-75 (2004) |
| 9 | 2004 | Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. | 
| + | - | nl | Cardiovasc Res 63(3):476-86 (2004) |
| 10 | 2004 | Myocyte hypertrophy and apoptosis: a balancing act. | 
| + | - | nl | Cardiovasc Res 63(3):487-99 (2004) |
| 11 | 2004 | Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. | 
| + | - | nl | Cardiovasc Res 63(3):373-80 (2004) |
| 12 | 2008 | Leptin-induced cardiac hypertrophy: RhoAing a lipid raft down a protective p38 MAPK signalling stream? | 
| + | - | nl | Cardiovasc Res 77(1):4-5 (2008) |
| 13 | 2005 | Genetics of left ventricular hypertrophy and its regression. | 
| + | - | nl | Rev Port Cardiol 24(1):105-17 (2005) |
| 14 | 2002 | Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy. | 
| + | - | nl | Endocr J 49(1):1-13 (2002) |
| 15 | 2011 | New molecular mechanisms for cardiovascular disease: cardiac hypertrophy and cell-volume regulation. | 
| + | - | nl | J Pharmacol Sci 116(4):343-9 (2011) |
| 16 | 2007 | Re-employment of developmental transcription factors in adult heart disease. | 
| + | - | nl | Semin Cell Dev Biol 18(1):117-31 (2007) |
| 17 | 2008 | Factors and mechanisms involved in left ventricular hypertrophy and the anti-hypertrophic role of nitric oxide. | 
| + | - | nl | Arq Bras Cardiol 90(6):409-16 (2008) |